Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Implant retained overdentures are a cost-effective treatment for elderly patients suffering from complete tooth loss. Despite the high success rate of implants in the general population, older adults lacking all teeth are a challenging population for implant therapy, often presenting limited bone disponibility, narrow alveolar ridges, diminished bone density, scarce inserted gingiva and several co-morbidities.Thus, improving their possibility of success in implant therapy avoiding further surgical interventions is key.
Platelet-rich fibrin (PRF) is a blood derivate that can be easily and economically obtained from patients and that has shown promise of reducing the complications and improving the success of implant therapy, nevertheless its benefits in patients receiving implant retained overdentures has not been stablished. It is possible that PRF can improve the results and diminish the complications of implant therapy in older adults.
The investigation aims to demonstrate that the use of platelet-rich fibirn (PRF) is safe and beneficial for implant treatment in older adults suffering from complete tooth loss.
The investigators will conduct a split-mouth design randomized clinical trial assessing the effect of PRF in primary stability and bone/soft tissue healing around mandibular implants in edentulous elderly adults.
Aim and purpose
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Implant installation with PRF | Experimental | PRF membrane over the buccal aspect of implant site |
|
| Implant installation without PRF | Active Comparator | Implant installation contralateral to the the experimental implant, without PRF membrane |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Implant installation with PRF membrane | Procedure | Platelet-rich fibrin membrane over the buccal aspect of implant site after dental implant installation |
|
| Measure | Description | Time Frame |
|---|---|---|
| Implant stability | primary implant stability of mandibular implants in edentulous patients using resonance frequency analysis (RFA). | 6 months |
| Measure | Description | Time Frame |
|---|---|---|
| Keratinized tissue thickness around implant neck | Distance in mm from the surface of keratinized gingiva 1 mm apical to implant neck to bone contact | 6 months |
| Keratinized tissue width around implant neck |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Franco Cavalla, DDS PhD | Contact | +56932035746 | icavalla@odontologia.uchile.cl | |
| Patricio Neira, DDS | Contact | +56995193394 | pneira@odontologia.uchile.cl |
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| San Camilo Hospital | Recruiting | San Felipe | Aconcagua | 969696 | Chile |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D007575 | Jaw, Edentulous |
| ID | Term |
|---|---|
| D007571 | Jaw Diseases |
| D009140 | Musculoskeletal Diseases |
| D009057 | Stomatognathic Diseases |
| D009066 | Mouth, Edentulous |
Not provided
Not provided
We will conduct a split-mouth design randomized clinical trial
Not provided
Not provided
Allocation sequence will be masked from participant, outcome assessor and statistician
| Implant installation without PRF membrane | Procedure | Implant installation contralateral to the experimental side without PRF membrane |
|
Distance in mm of keratinized tissue from implant neck to mucogingival junction
| 6 months |
| D009059 |
| Mouth Diseases |
| D014076 | Tooth Diseases |